Literature DB >> 18668556

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.

Camilla Jandus1, Gilles Bioley, Jean-Paul Rivals, Jean Dudler, Daniel Speiser, Pedro Romero.   

Abstract

OBJECTIVE: A distinct subset of proinflammatory CD4+ T cells that produce interleukin-17 was recently identified. These cells are implicated in different autoimmune disease models, such as experimental autoimmune encephalomyelitis and collagen-induced arthritis, but their involvement in human autoimmune disease has not yet been clearly established. The purpose of this study was to assess the frequency and functional properties of Th17 cells in healthy donors and in patients with different autoimmune diseases.
METHODS: Peripheral blood was obtained from 10 psoriatic arthritis (PsA), 10 ankylosing spondylitis (AS), 10 rheumatoid arthritis (RA), and 5 vitiligo patients, as well as from 25 healthy donors. Synovial tissue samples from a separate group of patients were also evaluated (obtained as paraffin-embedded sections). Peripheral blood cells were analyzed by multiparameter flow cytometry and immunohistochemistry. Cytokine production was examined by enzyme-linked immunosorbent assay and intracellular cytokine staining using specific monoclonal antibodies. Synovial tissue was examined for infiltrating T cells by immunohistochemical analysis.
RESULTS: We found increased numbers of circulating Th17 cells in the peripheral blood of patients with seronegative spondylarthritides (PsA and AS), but not in patients with RA or vitiligo. In addition, Th17 cells from the spondylarthritis patients showed advanced differentiation and were polyfunctional in terms of T cell receptor-driven cytokine production.
CONCLUSION: These observations suggest a role of Th17 cells in the pathogenesis of certain human autoimmune disorders, in particular the seronegative spondylarthritides.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668556     DOI: 10.1002/art.23655

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  141 in total

1.  IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist.

Authors:  Frank L van de Veerdonk; Angela K Stoeckman; Gouping Wu; Aaron N Boeckermann; Tania Azam; Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Ruyi Hao; Vassili Kalabokis; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

Review 2.  Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond.

Authors:  Robert A Colbert
Journal:  Nat Rev Rheumatol       Date:  2010-07-06       Impact factor: 20.543

3.  Evaluation of the T helper 17 axis in ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Didem L Kozaci; Arif Yuksel; Safak Bilge; Yasar Yildiz; Gulten Sop; Isil Coker; Necati Gunay; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 4.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 5.  Secukinumab: a promising therapeutic option in spondyloarthritis.

Authors:  Hernan Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2016-07-20       Impact factor: 2.980

6.  Overexpression and unique rearrangement of VH2 transcripts in immunoglobulin variable heavy chain genes in ankylosing spondylitis patients.

Authors:  Yeon Joo Kim; Na Young Kim; Min Kyung Lee; Hyo Jin Choi; Han Joo Baek; Chang Hoon Nam
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

Review 7.  [Th17 cells - a new proinflammatory T cell population and its role in rheumatologic autoimmune diseases].

Authors:  J Leipe; A Skapenko; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

8.  IL-23 and IL-17 in ankylosing spondylitis.

Authors:  Daniel Wendling
Journal:  Rheumatol Int       Date:  2009-11-04       Impact factor: 2.631

9.  Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.

Authors:  D N Hull; R O Williams; E Pathan; S Alzabin; S Abraham; P C Taylor
Journal:  Clin Exp Immunol       Date:  2015-06-23       Impact factor: 4.330

Review 10.  Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis.

Authors:  Ennio Lubrano; Fabio Massimo Perrotta
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.